CD4 c.681T>C ;(p.F227=)

Variant ID: 12-6925295-T-C

NM_000616.4(CD4):c.681T>C;(p.F227=)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week.

Journal Of Acquired Immune Deficiency Syndromes (1999)
Schürmann, Dirk D; Jackson Rudd, Deanne D; Schaeffer, Andrea A; De Lepeleire, Inge I; Friedman, Evan J EJ; Robberechts, Martine M; Zhang, Saijuan S; Liu, Yang Y; Kandala, Bhargava B; Keicher, Christian C; Däumer, Martin M; Hofmann, Jörg J; Grobler, Jay A JA; Stoch, S Aubrey SA; Iwamoto, Marian M; Ankrom, Wendy W
Publication Date: 2022-02-01

Variant appearance in text: CD4: F227F
PubMed Link: 34654041
Variant Present in the following documents:
  • Main text
View BVdb publication page



Single oral doses of MK-8507, a novel non-nucleoside reverse transcriptase inhibitor, suppress HIV-1 RNA for a week.

Journal Of Acquired Immune Deficiency Syndromes (1999)
Schürmann, Dirk D; Rudd, Deanne Jackson DJ; Schaeffer, Andrea A; De Lepeleire, Inge I; Friedman, Evan J EJ; Robberechts, Martine M; Zhang, Saijuan S; Liu, Yang Y; Kandala, Bhargava B; Keicher, Christian C; Däumer, Martin M; Hofmann, Jörg J; Grobler, Jay A JA; Stoch, S Aubrey SA; Iwamoto, Marian M; Ankrom, Wendy W
Publication Date: 2021-10-13

Variant appearance in text: CD4: F227F
PubMed Link: 34654041
Variant Present in the following documents:
  • Main text
View BVdb publication page



Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.

Viruses
Porter, Danielle P DP; Daeumer, Martin M; Thielen, Alexander A; Chang, Silvia S; Martin, Ross R; Cohen, Cal C; Miller, Michael D MD; White, Kirsten L KL
Publication Date: 2015-12-07

Variant appearance in text: CD4: F227F
PubMed Link: 26690199
Variant Present in the following documents:
  • Main text
  • viruses-07-02943.pdf
View BVdb publication page



Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia.

Plos One
Llibre, Josep M JM; Bravo, Isabel I; Ornelas, Arelly A; Santos, José R JR; Puig, Jordi J; Martin-Iguacel, Raquel R; Paredes, Roger R; Clotet, Bonaventura B
Publication Date: 2015

Variant appearance in text: CD4: F227F
PubMed Link: 26107265
Variant Present in the following documents:
  • Main text
  • pone.0128131.pdf
View BVdb publication page